T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$7.49B |
| 2 |
Micron Technology
MU
|
+$6.62B |
| 3 |
Lam Research
LRCX
|
+$3.45B |
| 4 |
Applied Materials
AMAT
|
+$3.03B |
| 5 |
Advanced Micro Devices
AMD
|
+$2.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$12.1B |
| 2 |
Apple
AAPL
|
+$11.6B |
| 3 |
Amazon
AMZN
|
+$3.54B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.07B |
| 5 |
Keysight
KEYS
|
+$1.82B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.73% |
| 2 | Healthcare | 11.3% |
| 3 | Financials | 10.32% |
| 4 | Communication Services | 9.66% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Evolus
EOLS
$526M
| $957K | ﹤0.01% |
137,761
+39,797
| +41% | +$235K |
|
2352
MBIA
MBI
$224M
| $956K | ﹤0.01% |
146,561
+27,706
| +23% | +$167K |
|
2353
LSB Industries
LXU
$712M
| $953K | ﹤0.01% |
88,136
+17,501
| +25% | +$234K |
|
2354
Monro
MNRO
$430M
| $953K | ﹤0.01% |
55,658
+10,384
| +23% | +$170K |
|
2355
United States Lime & Minerals
USLM
$3.2B
| $950K | ﹤0.01% |
9,073
+1,380
| +18% | +$160K |
|
|
TRTX
2356
TPG RE Finance Trust
TRTX
$504M
| $947K | ﹤0.01% |
113,030
+6,015
| +6% | +$50.2K |
|
2357
Columbus McKinnon
CMCO
$486M
| $942K | ﹤0.01% |
62,255
+24,282
| +64% | +$362K |
|
2358
Nordic American Tanker
NAT
$1.63B
| $938K | ﹤0.01% |
169,314
+19,837
| +13% | +$112K |
|
2359
NETGEAR
NTGR
$600M
| $938K | ﹤0.01% |
40,163
+5,353
| +15% | +$133K |
|
|
UHT
2360
Universal Health Realty Income Trust
UHT
$537M
| $936K | ﹤0.01% |
21,321
+1,894
| +10% | +$77.8K |
|
|
INN
2361
Summit Hotel Properties
INN
$619M
| $935K | ﹤0.01% |
133,312
+6,924
| +5% | +$38.2K |
|
|
INVX
2362
Innovex International
INVX
$1.99B
| $935K | ﹤0.01% |
37,675
+9,963
| +36% | +$271K |
|
2363
Flexsteel Industries
FLXS
$366M
| $928K | ﹤0.01% |
12,450
+1,728
| +16% | +$96.8K |
|
|
FRMI
2364
Fermi Inc
FRMI
$2.89B
| $928K | ﹤0.01% |
101,210
+84,349
| +500% | +$533K |
|
2365
Ginkgo Bioworks
DNA
$718M
| $927K | ﹤0.01% |
93,528
-8,783
| -9% | -$73.5K |
|
2366
Ranpak Holdings
PACK
$376M
| $927K | ﹤0.01% |
126,791
+21,636
| +21% | +$125K |
|
2367
Perella Weinberg Partners
PWP
$1.12B
| $922K | ﹤0.01% |
57,716
+13,146
| +29% | +$240K |
|
2368
Coty
COTY
$2.33B
| $918K | ﹤0.01% |
424,727
+145,348
| +52% | +$313K |
|
2369
Kearny Financial
KRNY
$591M
| $918K | ﹤0.01% |
97,007
+500
| +0.5% | +$4.12K |
|
|
TRAX
2370
First Tracks Biotherapeutics
TRAX
$1.23B
| $911K | ﹤0.01% |
+45,232
| New | +$846K |
|
2371
Rapid7
RPD
$783M
| $910K | ﹤0.01% |
112,277
+22,607
| +25% | +$150K |
|
2372
Precigen
PGEN
$2.77B
| $905K | ﹤0.01% |
158,614
+19,438
| +14% | +$84K |
|
2373
Manitowoc
MTW
$798M
| $900K | ﹤0.01% |
64,791
+13,809
| +27% | +$175K |
|
2374
Titan International
TWI
$456M
| $899K | ﹤0.01% |
116,585
+36,976
| +46% | +$285K |
|
2375
Dole
DOLE
$1.23B
| $898K | ﹤0.01% |
65,429
+17,687
| +37% | +$257K |
|
Similar funds
T. Rowe Price Associates's Q2 2026 Portfolio in Review
As of Q2 2026, T. Rowe Price Associates held 3,356 positions worth $999B, up 16% from $865B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q2 2026 filing shows 224 new, 2,237 increased, 645 reduced and 116 closed positions. Its largest new stake was SpaceX: 10,709,016 shares worth $1.83B. The largest sale was Microsoft, an estimated $12.1B.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2026 buy was SpaceX: 10,709,016 shares worth $1.83B.
- T. Rowe Price Associates added most to Alphabet (Google) Class A in Q2 2026, an estimated $7.49B increase.
- T. Rowe Price Associates's biggest Q2 2026 reduction was Microsoft, cutting an estimated $12.1B.
- T. Rowe Price Associates fully exited Sibanye-Stillwater in Q2 2026, selling an estimated $40.4M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $999B portfolio in Q2 2026.
- T. Rowe Price Associates opened 224 new positions and closed 116 in Q2 2026.
- T. Rowe Price Associates's portfolio value rose 16% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.